| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Joan E Herman is Director at IONS and has filed Form 4s across 2 companies. Joan E Herman's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.8M at current prices.
The biggest single holding is EHC (~$6.7M) as Director.
Joan E Herman has 68 Form 4 filings on record from July 2017 to October 2026, across 2 companies: Director at Encompass Health (EHC), 2017–2026; Director at Ionis Pharmaceuticals (IONS), 2019–2026.
The 83 reported transactions were 47 stock awards, 18 option or other derivative awards, 16 option exercises and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $3.2M.
The only open-market sale was 44,000 shares of IONS at an average $72.13 on November 19, 2025, about $3.2M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 44,000 | $72.13 | $3,173,830.00 | -48.8% | +9.9% | - |